treczimus 0.03% 20gm

Treczimus 0.03% ointment contains Tacrolimus, a topical calcineurin inhibitor. It is primarily indicated for the short-term and intermittent long-term treatment of moderate to severe atopic dermatitis in patients who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. By modulating the immune response in the skin, it helps reduce inflammation, redness, and itching associated with eczema. This product is intended for external use only and should be applied as directed by a healthcare professional to ensure safety and efficacy in managing chronic skin conditions.